1. Pharmaceuticals and Drug Development

U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome

Written by Posted on Less than 0 min read

Copenhagen, Denmark, December 19, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Antarctic ‘greening’ at dramatic rate

Vegetation cover across the Antarctic Peninsula has increased more than tenfold over the last four decades, new research shows. The Antarctic Peninsula, like many polar regions, is warming faster than the global average, with extreme heat events in Antarctica becoming more common. The new study — by the universities of Exeter and Hertfordshire, and the […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Mapping the sex life of Malaria parasites at single cell resolution, reveals the genetics underlying Malaria transmission

Malaria is caused by a eukaryotic microbe of the Plasmodium genus, and is responsible for more deaths than all other parasitic diseases combined. In order to transmit from the human host to the mosquito vector, the parasite has to differentiate to its sexual stage, referred to as the gametocyte stage. Unlike primary sex determination in […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Cell’s ‘rubbish disposal’ could have one other position: Serving to neurons close to pores and skin sense the atmosphere

The standard job of the proteasome, the rubbish disposal of the cell, is to grind down proteins into smaller bits and recycle a few of these bits and components. That is nonetheless the case, for essentially the most half, however, Johns Hopkins Drugs researchers, finding out nerve cells grown within the lab and mice, say […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Humpbacks are among animals who manufacture and wield tools

In a study published today in Royal Society Open Science, researchers at the Marine Mammal Research Program (MMRP) at UH Hawai’i Institute of Marine Biology (HIMB) and Alaska Whale Foundation (AWF) consider a new designation of the humpback whales they study: tool wielders. Researchers have known that humpback whales create “bubble-nets” to hunt, but they […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

American lobster population, habitat preferences shifting, study finds

American lobsters along Maine’s coast have relocated to new habitats, while the population simultaneously shrunk in abundance and grew older, according to a new study by University of Maine researchers. For decades, the vast majority of adult lobsters resided in boulder shelter habitats. This knowledge helped inform longtime conservation efforts and regulations within the more […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Study on architecture of heart offers new understanding of human evolution

An international research team from Swansea University and UBC Okanagan (UBCO) has uncovered a new insight into human evolution by comparing humans’ hearts with those of other great apes. Despite humans and non-human great apes having a common ancestor, the former has evolved larger brains and the ability to walk or run upright on two […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Myths about intermittent fasting, debunked

In a new article, researchers at the University of Illinois Chicago debunk four common myths about the safety of intermittent fasting. Intermittent fasting has become an increasingly popular way to lose weight without counting calories. And a large body of research has shown it’s safe. Still, several myths about fasting have gained traction among clinicians, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Evolution of taste: Early sharks were able to perceive bitter substances

A research team from the University of Cologne, in collaboration with colleagues from the Leibniz Institute for Food Systems Biology in Freising, has discovered a receptor for bitter taste in twelve different cartilaginous fish (sharks and rays). The receptor belongs to the so-called taste receptors type 2 (T2R), which also make humans perceive bitter and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Amgen Presents New Data From Phase 2 Trial of Dazodalibep in Sjögren’s Syndrome

THOUSAND OAKS, Calif., Nov. 7, 2023. Amgen (NASDAQ:AMGN) today announced new data from its Phase 2 study evaluating dazodalibep, an investigational medicine, for the treatment of Sjögren’s. These results will be featured in presentations at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15, in San Diego. Findings from the study demonstrate that dazodalibep […]
Written by
  1. Clinical

Decrease Dose of Mpox Vaccine is Secure and Generates Six-Week Antibody Response Equal to Commonplace Routine

April 27, 2024 — A dose-sparing intradermal mpox vaccination routine was protected and generated an antibody response equal to that induced by the usual routine at six weeks (two weeks after the second dose), based on findings offered immediately on the European Society of Scientific Microbiology and Infectious Ailments World Congress in Barcelona. The outcomes […]
Written by
  1. Clinical

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

CARLSBAD, Calif., July 18, 2024. Ionis Pharmaceuticals, Inc. announced today that it has completed enrollment in the pivotal trial of zilganersen (ION373), an investigational RNA-targeted medicine in development for the treatment of children and adults with a rare, progressive and ultimately fatal neurological disorder known as Alexander disease (AxD). The primary endpoint is percent change […]
Written by
  1. Clinical

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

SOUTH SAN FRANSCISO, Calif., June 04, 2024. Surrozen, Inc. (“Surrozen” or the “Company”), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced that the first patient has been dosed in its Phase 1b clinical trial for SZN-043 in patients with severe alcohol-associated hepatitis. The Phase 1b […]
Written by
  1. Clinical

Getting Paid for Your Participation: Exploring Clinical Studies

Participating in clinical studies not only allows you to contribute to medical advancements but also gives you the opportunity to earn some extra cash. Clinical studies are essential for the development of new medicines, treatments, and therapies. These studies need individuals from various backgrounds who are willing to be part of the research process. If […]
Written by
  1. Clinical

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the “Company”, together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group has completed STP707 Phase I clinical study with strong safety profile and […]
Written by
  1. Clinical

Harnessing the Power of Clinical Trials for Health and Wellness

Clinical trials play a crucial role in advancing health and wellness by harnessing the power of scientific research to develop innovative treatments, therapies, and preventive measures. These trials are carefully designed studies that evaluate the effectiveness and safety of new drugs, medical devices, diagnostic tools, or interventions. The primary goal of clinical trials is to […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

May 20, 2024 — The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept products work by inhibiting vascular endothelial growth factor (VEGF) which prevents abnormal blood vessel growth within the eye. By blocking VEGF, aflibercept products can slow down or reduce damage to the retina and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

Generic name: apomorphineTreatment for: Hypomobility in Parkinson’s Disease Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA ROCKVILLE, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the […]
Written by
  1. Biology

As dogs age, their owner-assessed quality of life predictably declines,

As dogs age, their owner-assessed quality of life predictably declines, with higher mortality seen at quality of life below 76% of the maximum score – though many dogs have high quality of life even when at predicted lifespan Credit: Juli Leonard for the Canine Neuroaging Program, CC-BY 4.0 ( As dogs age, their owner-assessed quality […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.